15250-m-cuypers

187 Decision aid uptake and usage in clinical practice 9 15. van der Weijden T, Post H, Brand PLP, van Veenendaal H, Drenthen T, van Mierlo LAJ, et al. Shared decision making, a buzz-word in the Netherlands, the pace quickens towards nationwide implementation…. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen. 2017;123-124:69-74. 16. Cuypers M, Lamers RE, Kil PJ, The R, Karssen K, Poll-Franse LVvd, et al. A global, incremental development method for a web-based prostate cancer treatment decision aid and usability testing in a Dutch clinical setting. Health Informatics Journal.0(0):1460458217720393. 17. Cuypers M, Lamers RED, Kil PJM, van de Poll-Franse LV, de Vries M. Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial. Trials. 2015;16(1):1-10. 18. D'Amico AV, Whittington R, Malkowicz S, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969-74. 19. Grol R, Wensing M, Eccles M, Davis D. Improving patient care: the implementation of change in health care: John Wiley & Sons; 2013. 20. Al-Itejawi HHM, van Uden-Kraan CF, Vis AN, Nieuwenhuijzen JA, HofsteeMJA, vanMoorselaar RJA, et al. Development of a patient decision aid for the treatment of localised prostate cancer: a participatory design approach. Journal of Clinical Nursing. 2016;25(7-8):1131-44. 21. Cuypers M, Lamers RED, Kil PJM, Van de Poll-Franse LV, De Vries M. Oncology providers’ evaluation of the use of a prostate cancer treatment decision aid versus usual information provision: Results from the PCPCC trial European Journal for Person Centered Healthcare 2017; 5(4):433-440. 22. Pierorazio PM, Walsh PC, Partin AW, Epstein JI. Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. BJU International. 2013;111(5):753-60. 23. Schwartz B, editor The paradox of choice2004: Ecco New York. 24. Bundorf MK, Szrek H. Choice Set Size and Decision-Making: The Case of Medicare Part D Prescription Drug Plans. Medical decision making : an international journal of the Society for Medical Decision Making. 2010;30(5):582-93. 25. Hills TT, Noguchi T, Gibbert M. Information overload or search-amplified risk? Set size and order effects on decisions fromexperience. Psychonomic Bulletin & Review. 2013;20(5):1023- 31. 26. Brackett C, Kearing S, Cochran N, Tosteson A, Blair BrooksW. Strategies for distributing cancer screening decision aids in primary care. Patient Educ Couns. 2010;78. 27. Violette PD, Agoritsas T, Alexander P, Riikonen J, Santti H, Agarwal A, et al. Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis. CA: A Cancer Journal for Clinicians. 2015;65(3):239-51.